BSEOthers31 Jul 2026 · 31 Jul 2026, 02:42 pm
Please find attached the outcome of board meeting held on 31st July, 2026.
Cresanto Global Ltd · 531207
✦ AI SummaryRelated Party
Cresanto Global Ltd has announced the outcome of its board meeting held on July 31, 2026, where it considered and approved material related party transactions with its promoters and non-executive directors, Urmila Hansraj Sharma, Hitesh Bajoria, Nishant Nathmal Bajaj, and Prashant Nathmal Bajaj.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern6/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Cresanto Global Ltd - 531207 - Board Meeting Outcome for Meeting Held Today July 31, 2026
Attachments (1)
📄pdf
Download →
8128706a-2c5e-4f86-ae0c-e3dffe5dece5.pdf
View document text
CRESANTO GLOBAL LIMITED
(Formerly known as Raymed Labs Limited)
CIN: L22203UP1992PLC014240
Corporate Office: 201, 2nd Floor, A wing, Corporate Avenue, Sonawale Lane,
Goregaon East, Mumbai, Maharashtra 400063
Reg.off. -C- 273, C block, sector 63, Gautam Buddha Nagar, Noida, Uttar Pradesh,
India, 201301, Website- www.cresantoglobal.com
Email- raymedlabs@rediffmail.com, Phone no. 7738669898
BSE Limited,
Phiroze Jeejeebhoy
Towers, Dalal Street,
Mumbai - 400 001.
Scrip code: 531207
Subject: Outcome of Board Meeting
Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015.
Dear Sir/Madam,
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), we wish to inform
you that the Board of Directors of the Company at its meeting held today i.e., 31st July,
2026, has inter alia considered and approved the following matters:
1. Material Related Party Transaction(s) under section 188 of the Companies Act, 2013 and
Regulation 23 of SEBI (LODR) Regulations, 2015.
Disclosure of information pursuant to Regulation 30 of the SEBI (Listing Obligations and
Disclosure Requirements) Regulation, 2015, read with SEBI Master Circular No.
SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November, 2024 are attached as “Annexure-A”.
The meeting commenced at 02:15 p.m. and concluded at 02:30 p.m.
Kindly take the same on record.
CRESANTO GLOBAL LIMITED
(Formerly known as Raymed Labs Limited)
CIN: L22203UP1992PLC014240
Corporate Office: 201, 2nd Floor, A wing, Corporate Avenue, Sonawale Lane,
Goregaon East, Mumbai, Maharashtra 400063
Reg.off. -C- 273, C block, sector 63, Gautam Buddha Nagar, Noida, Uttar Pradesh,
India, 201301, Website- www.cresantoglobal.com
Email- raymedlabs@rediffmail.com, Phone no. 7738669898
For Cresanto Global Limited
(Formerly known as Raymed Labs Limited)
(Prashant Nathmal Bajaj)
Managing Director
DIN: 06634046
Date: 31st July, 2026
Place: Mumbai
CRESANTO GLOBAL LIMITED
(Formerly known as Raymed Labs Limited)
CIN: L22203UP1992PLC014240
Corporate Office: 201, 2nd Floor, A wing, Corporate Avenue, Sonawale Lane,
Goregaon East, Mumbai, Maharashtra 400063
Reg.off. -C- 273, C block, sector 63, Gautam Buddha Nagar, Noida, Uttar Pradesh,
India, 201301, Website- www.cresantoglobal.com
Email- raymedlabs@rediffmail.com, Phone no. 7738669898
“Annexure-A”
Disclosure of information pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulation, 2015, read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155
dated 11th November, 2024
Sr. Particulars Information
1. Name of the related party 1. Urmila Hansraj Sharma (Promoter & Non-
Executive Director)
2. Hitesh Bajoria (Promoter & Non-Executive
Director)
3. Nishant Nathmal Bajaj (Promoter & Non-
Executive Director)
4. Prashant Nathmal Bajaj (Promoter &
Managing Director)
2. Nature of relationship [including nature The above related parties have significance
of its interest (financial or otherwise)] influence over the reporting entity and falls
under the related party under Section 2(76) of
the Act and Regulation 2(1)(zb) of the SEBI
Listing Regulations.
3. Type of the proposed transaction The Company proposes to enter into such
Transaction(s)/ contract(s)/ Arrangement(s)/
Agreement(s)/ loan transaction(s)/ to extend or
avail the corporate guarantee in lieu of loan
taken and such other business transaction(s) as
and when required by and inter-se.
4. Nature, duration/tenure, material terms, Transactions in the normal course of business
CRESANTO GLOBAL LIMITED
(Formerly known as Raymed Labs Limited)
CIN: L22203UP1992PLC014240
Corporate Office: 201, 2nd Floor, A wing, Corporate Avenue, Sonawale Lane,
Goregaon East, Mumbai, Maharashtra 400063
Reg.off. -C- 273, C block, sector 63, Gautam Buddha Nagar, Noida, Uttar Pradesh,
India, 201301, Website- www.cresantoglobal.com
Email- raymedlabs@rediffmail.com, Phone no. 7738669898
monetary value and particulars of with terms and conditions that are generally
contract/ arrangement prevalent in the industry segments that the
company is operating in. Monetary value of
transactions subject to a maximum as below
through contracts/arrangements for a period
from conclusion of the AGM held in the FY 26-27
to till the AGM to be held in the FY 27-28.
5. Particulars of the proposed transaction Same as point 3 above.
6. Tenure of the transaction Conclusion of the AGM held in the FY 26-27 to
till the AGM to be held in the FY 27-28.
7. Value of the proposed transaction 1. Urmila Hansraj Sharma (Promoter & Non-
Executive Director) – Rs. 5 crores
2. Hitesh Bajoria (Promoter & Non-Executive
Director) - Rs. 5 crores
3. Nishant Nathmal Bajaj (Promoter & Non-
Executive Director) - Rs. 5 crores
4. Prashant Nathmal Bajaj (Promoter &
Managing Director) - Rs. 5 crores